E. coli Secretome Metabolically Modulates MDA-MB-231 Breast Cancer Cells’ Energy Metabolism

Breast cancer (BC) is commonly diagnosed in women. BC cells are associated with altered metabolism, which is essential to support their energetic requirements, cellular proliferation, and continuous survival. The altered metabolism of BC cells is a result of the genetic abnormalities of BC cells. Risk factors can also enhance it, including age, lifestyle, hormone disturbances, etc. Other unknown BC-promoting risk factors are under scientific investigation. One of these investigated factors is the microbiome. However, whether the breast microbiome found in the BC tissue microenvironment can impact BC cells has not been studied. We hypothesized that E. coli, part of a normal breast microbiome with more presence in BC tissue, secretes metabolic molecules that could alter BC cells’ metabolism to maintain their survival. Thus, we directly examined the impact of the E. coli secretome on the metabolism of BC cells in vitro. MDA-MB-231 cells, an in vitro model of aggressive triple-negative BC cells, were treated with the E. coli secretome at different time points, followed by untargeted metabolomics analyses via liquid chromatography–mass spectrometry to identify metabolic alterations in the treated BC cell lines. MDA-MB-231 cells that were not treated were used as controls. Moreover, metabolomic analyses were performed on the E. coli secretome to profile the most significant bacterial metabolites affecting the metabolism of the treated BC cell lines. The metabolomics results revealed about 15 metabolites that potentially have indirect roles in cancer metabolism that were secreted from E. coli in the culture media of MDA-MB-231 cells. The cells treated with the E. coli secretome showed 105 dysregulated cellular metabolites compared to controls. The dysregulated cellular metabolites were involved in the metabolism of fructose and mannose, sphingolipids, amino acids, fatty acids, amino sugar, nucleotide sugar, and pyrimidine, which are vital pathways required for the pathogenesis of BC. Our findings are the first to show that the E. coli secretome modulates the BC cells’ energy metabolism, highlighting insights into the possibility of altered metabolic events in BC tissue in the actual BC tissue microenvironment that are potentially induced by the local bacteria. Our study provides metabolic data that could be as a basis for future studies searching for the underlying mechanisms mediated by bacteria and their secretome to alter the metabolism of BC cells.

[1]  A. A. Abdel Rahman,et al.  Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment , 2021, Metabolites.

[2]  Y. Alashban,et al.  Incidence trends of breast cancer in Saudi Arabia: A joinpoint regression analysis (2004–2016) , 2021 .

[3]  R. Pestell,et al.  Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors , 2021, Frontiers in Oncology.

[4]  J. Koo,et al.  Glucose Metabolism and Glucose Transporters in Breast Cancer , 2021, Frontiers in Cell and Developmental Biology.

[5]  T. Sun,et al.  Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer , 2021, Journal of Cancer.

[6]  Zhaohui Yu,et al.  Effect of the ACY-1 gene on HER2 and TRAIL expression in rectal carcinoma , 2021, Experimental and therapeutic medicine.

[7]  Weiqiang Lu,et al.  Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine , 2021, Frontiers in Oncology.

[8]  A. Steffan,et al.  From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy , 2021, International journal of molecular sciences.

[9]  P. Porter,et al.  Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics. , 2021, Journal of proteome research.

[10]  J. Xia,et al.  MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights , 2021, Nucleic Acids Res..

[11]  Giuseppina Augimeri,et al.  PPARgamma: A Potential Intrinsic and Extrinsic Molecular Target for Breast Cancer Therapy , 2021, Biomedicines.

[12]  B. Firestein,et al.  Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation , 2021, Cells.

[13]  B. Stecca,et al.  Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention? , 2021, Cancers.

[14]  Babita Singh,et al.  Role of protein S-Glutathionylation in cancer progression and development of resistance to anti-cancer drugs. , 2021, Archives of biochemistry and biophysics.

[15]  Peter S. Thuy-Boun,et al.  Identification of an N-acetylneuraminic acid-presenting bacteria isolated from a human microbiome , 2021, Scientific reports.

[16]  R. Tannenbaum,et al.  Evaluation of aromatic amino acids as potential biomarkers in breast cancer by Raman spectroscopy analysis , 2021, Scientific Reports.

[17]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[18]  Shizhen Zhang,et al.  The Metabolic Mechanisms of Breast Cancer Metastasis , 2021, Frontiers in Oncology.

[19]  A. Masood,et al.  Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus , 2020, Frontiers in Molecular Biosciences.

[20]  L. Ouyang,et al.  Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy. , 2020, Drug discovery today.

[21]  D. Skropeta,et al.  Insights into the role of sialylation in cancer progression and metastasis , 2020, British Journal of Cancer.

[22]  S. Grivennikov,et al.  Microbiome in cancer progression and therapy. , 2020, Current opinion in microbiology.

[23]  M. Maffia,et al.  Microbiota-Derived Metabolites in Tumor Progression and Metastasis , 2020, International journal of molecular sciences.

[24]  M. Agostini,et al.  Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment , 2020, Frontiers in Oncology.

[25]  A. Aboussekhra,et al.  Clinical and functional significance of tumor/stromal ATR expression in breast cancer patients , 2020, Breast Cancer Research.

[26]  D. Sharma,et al.  Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights , 2020, Cells.

[27]  X. Ji,et al.  Methionine Restriction and Cancer Biology , 2020, Nutrients.

[28]  L. B. Kouitcheu Mabeku,et al.  Potential of selected lactic acid bacteria from Theobroma cacao fermented fruit juice and cell-free supernatants from cultures as inhibitors of Helicobacter pylori and as good probiotic , 2020, BMC Research Notes.

[29]  Nikos Koundouros,et al.  Reprogramming of fatty acid metabolism in cancer , 2019, British Journal of Cancer.

[30]  S. Diggle,et al.  Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis , 2019, Molecular Cancer Research.

[31]  M. Manjili,et al.  The microbiome and breast cancer: a review , 2019, Breast Cancer Research and Treatment.

[32]  Ying Jiang,et al.  Metabolomics: a promising diagnostic and therapeutic implement for breast cancer , 2019, OncoTargets and therapy.

[33]  R. Drake,et al.  Glycosylation and its implications in breast cancer , 2019, Expert review of proteomics.

[34]  Xuan-Mai Petterson,et al.  A comprehensive protocol for multiplatform metabolomics analysis in patient-derived skin fibroblasts , 2019, Metabolomics.

[35]  M. Jacob,et al.  Metabolomics toward personalized medicine. , 2019, Mass spectrometry reviews.

[36]  J. Szabó,et al.  Microbiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored , 2019, Cells.

[37]  Keisuke Hikosaka,et al.  NAD Metabolism in Cancer Therapeutics , 2018, Front. Oncol..

[38]  M. Jacob,et al.  A targeted metabolomics approach for clinical diagnosis of inborn errors of metabolism. , 2018, Analytica chimica acta.

[39]  Ling Li,et al.  Expression of manB Gene from Escherichia coli in Lactococcus lactis and Characterization of Its Bifunctional Enzyme, Phosphomannomutase. , 2018, Journal of microbiology and biotechnology.

[40]  Claudio Luchinat,et al.  Metabolomics in breast cancer: A decade in review. , 2018, Cancer treatment reviews.

[41]  Tian Tian,et al.  Distinct Microbial Signatures Associated With Different Breast Cancer Types , 2018, Front. Microbiol..

[42]  Junjeong Choi,et al.  Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer , 2018, Disease markers.

[43]  J. Norman,et al.  Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells , 2017, Nature Communications.

[44]  Krishna R. Kalari,et al.  A comprehensive analysis of breast cancer microbiota and host gene expression , 2017, PloS one.

[45]  Sonja C. Stadler,et al.  Obesity and Breast Cancer: Current Insights on the Role of Fatty Acids and Lipid Metabolism in Promoting Breast Cancer Growth and Progression , 2017, Front. Endocrinol..

[46]  Yanfen Cui,et al.  Increased utilization of fructose has a positive effect on the development of breast cancer , 2017, PeerJ.

[47]  A. Lane,et al.  Probing the metabolic phenotype of breast cancer cells by multiple tracer stable isotope resolved metabolomics. , 2017, Metabolic engineering.

[48]  S. Mani Microbiota and Breast Cancer. , 2017, Progress in molecular biology and translational science.

[49]  E. Sloan,et al.  Optimized Method for Untargeted Metabolomics Analysis of MDA-MB-231 Breast Cancer Cells , 2016, Metabolites.

[50]  T. Wakai,et al.  High levels of sphingolipids in human breast cancer. , 2016, The Journal of surgical research.

[51]  G. Gloor,et al.  The Microbiota of Breast Tissue and Its Association with Breast Cancer , 2016, Applied and Environmental Microbiology.

[52]  Amir Mehrgou,et al.  The importance of BRCA1 and BRCA2 genes mutations in breast cancer development , 2016, Medical journal of the Islamic Republic of Iran.

[53]  Yun Yen,et al.  Lowered circulating aspartate is a metabolic feature of human breast cancer , 2015, Oncotarget.

[54]  Lei-lei Zhou,et al.  Tryptophan-induced pathogenesis of breast cancer. , 2015, African health sciences.

[55]  U. Günther Metabolomics Biomarkers for Breast Cancer , 2015, Pathobiology.

[56]  S. Ambs,et al.  Metabolic signatures of human breast cancer , 2015, Molecular & cellular oncology.

[57]  Yu‐Ju Chen,et al.  Glutathionylspermidine in the Modification of Protein SH Groups: The Enzymology and Its Application to Study Protein Glutathionylation , 2015, Molecules.

[58]  A. Caudy,et al.  Targeted metabolomics in cultured cells and tissues by mass spectrometry: method development and validation. , 2014, Analytica chimica acta.

[59]  J. Shamonki,et al.  Microbial Dysbiosis Is Associated with Human Breast Cancer , 2014, PloS one.

[60]  G. Zhu,et al.  New function for Escherichia coli xanthosine phophorylase (xapA): genetic and biochemical evidences on its participation in NAD+ salvage from nicotinamide , 2014, BMC Microbiology.

[61]  F. Fogolari,et al.  Absolute Quantification of Choline-Related Biomarkers in Breast Cancer Biopsies by Liquid Chromatography Electrospray Ionization Mass Spectrometry , 2013, Analytical cellular pathology.

[62]  Geert Postma,et al.  Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery , 2013, PloS one.

[63]  F. Romero,et al.  Cell-Free Culture Supernatant of Bifidobacterium breve CNCM I-4035 Decreases Pro-Inflammatory Cytokines in Human Dendritic Cells Challenged with Salmonella typhi through TLR Activation , 2013, PloS one.

[64]  Robert Powers,et al.  Multivariate Analysis in Metabolomics. , 2012, Current Metabolomics.

[65]  Ram Krishnamurthy,et al.  ECMDB: The E. coli Metabolome Database , 2012, Nucleic Acids Res..

[66]  C. Perou,et al.  Impact of Tumor Microenvironment and Epithelial Phenotypes on Metabolism in Breast Cancer , 2012, Clinical Cancer Research.

[67]  A. Aboussekhra,et al.  p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition. , 2012, Neoplasia.

[68]  F. Sotgia,et al.  Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance , 2012, Cell cycle.

[69]  O. Muzik,et al.  Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies. , 2012, Nuclear medicine and biology.

[70]  V. Mootha,et al.  Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation , 2012, Science.

[71]  Oliver Fiehn,et al.  Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study , 2012, BMC Genomics.

[72]  P. Wood,et al.  Detection of N‐acetyl methionine in human and murine brain and neuronal and glial derived cell lines , 2011, Journal of neurochemistry.

[73]  Matej Oresic,et al.  Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. , 2011, Cancer research.

[74]  A. Aboussekhra,et al.  Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. , 2008, Cancer research.

[75]  Ulrich Genschel Coenzyme A biosynthesis: reconstruction of the pathway in archaea and an evolutionary scenario based on comparative genomics. , 2004, Molecular biology and evolution.

[76]  C. Brenner,et al.  Discoveries of Nicotinamide Riboside as a Nutrient and Conserved NRK Genes Establish a Preiss-Handler Independent Route to NAD+ in Fungi and Humans , 2004, Cell.

[77]  R. Kolter,et al.  Glutathionylspermidine Metabolism in Escherichia coli. , 1995, The Journal of Biological Chemistry.

[78]  J. Lobry,et al.  Maintenance requirements of Escherichia coli ATCC 25922 in the presence of sub-inhibitory concentrations of various antibiotics. , 1992, The Journal of antimicrobial chemotherapy.